Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diversified Healthcare Trust (DHCNL) EBIT (2016 - 2025)

Historic EBIT for Diversified Healthcare Trust (DHCNL) over the last 17 years, with Q3 2025 value amounting to -$190.1 million.

  • Diversified Healthcare Trust's EBIT fell 5619.18% to -$190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$557.2 million, marking a year-over-year decrease of 5951.3%. This contributed to the annual value of -$444.7 million for FY2024, which is 1270.33% down from last year.
  • As of Q3 2025, Diversified Healthcare Trust's EBIT stood at -$190.1 million, which was down 5619.18% from -$117.6 million recorded in Q2 2025.
  • Diversified Healthcare Trust's EBIT's 5-year high stood at $430.7 million during Q4 2021, with a 5-year trough of -$190.1 million in Q3 2025.
  • For the 5-year period, Diversified Healthcare Trust's EBIT averaged around -$17.4 million, with its median value being -$31.0 million (2023).
  • As far as peak fluctuations go, Diversified Healthcare Trust's EBIT skyrocketed by 515076.87% in 2022, and later crashed by 232663.07% in 2024.
  • Diversified Healthcare Trust's EBIT (Quarter) stood at $430.7 million in 2021, then crashed by 103.13% to -$13.5 million in 2022, then tumbled by 130.22% to -$31.0 million in 2023, then plummeted by 307.32% to -$126.5 million in 2024, then tumbled by 50.31% to -$190.1 million in 2025.
  • Its EBIT stands at -$190.1 million for Q3 2025, versus -$117.6 million for Q2 2025 and -$123.0 million for Q1 2025.